-
New study shows that daily multivitamins may ameliorate Alzheimer's disease
September 21st is World Alzheimer's Day. The survey report on the awareness and demand of Alzheimer's disease in China was released recently.
2022-09-23 16:12 -
Zebutinib recommended as 'Class I priority' in international guidelines
The National Comprehensive Cancer Network (NCCN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Guidelines, First Edition 2023, wer...
2022-09-19 10:03 -
The Third Domestic Company: Kelun Pharmaceuticals Submits a Listing Application for 'Olaparib'
On September 8, according to CDE's official website, Kelun Pharmaceuticals submitted a marketing application for Olaparib category 4 generic drugs
2022-09-09 14:23 -
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
On the evening of August 26, the announcement of the results of the 57threview meeting of the GEM Listing Committee in 2022 showed that Hubei Hongyuan...
2022-09-02 16:20 -
The Overall Veterinary Drug API Market was Weak in August, and the Pattern Continued or Difficult to...
Entering August, the market situation of veterinary drug raw materials changed abruptly, the price stagnation was obvious, the market demand recovery ...
2022-09-01 16:39 -
The First Capsid Inhibitor: Lenacapavir, a Shining Star in the Field of Anti-AIDS Drugs
Recently, Gilead Sciences announced that its novel HIV antiviral capsid inhibitor Lenacapavir (Sunlenca) received marketing authorization from the Eur...
2022-09-01 15:40 -
The Pattern Changes of the Global API Industry and the Analysis of Future Development Trends, What a...
Over the years, APIs have always occupied the highest proportion in my country's export trade of pharmaceutical products. China's API industry also oc...
2022-08-30 15:24 -
First BCMA/CD3 dual antibodies approved by EU
On August 24, Johnson & Johnson/Janssen announced that the European Commission (EC) has granted conditional marketing approval for teclistamab
2022-08-29 17:24 -
FDA approves 'ibrutinib' for chronic graft-versus-host disease in children 1 year and older
On August 24, Janssen, a Johnson & Johnson company, announced that the FDA approved the BTK inhibitor ibrutinib (ibrutinib) for the treatment of patie...
2022-08-29 17:23 -
Can fish oil replace statin lipid-lowering medications?
Many studies on deep-sea fish oil in recent years have found that it does not actually prevent cardiovascular disease. On the one hand, it is because ...
2022-08-29 17:21
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
